Form 4: National HealthCare Director Receives Stock Option Grant

Director David R. Gifford was granted 7,500 stock options in National HealthCare Corp as part of the 2020 Omnibus Equity Incentive Plan.

Summary

• Director David R. Gifford received a grant of 7,500 stock options for National HealthCare Corp (NHC) common stock.
• The options were granted on May 7, 2026, with an exercise price of $171.42 per share.
• The options are exercisable immediately and expire on May 6, 2030.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral administrative filing reflecting standard director compensation practices.

Positives

• Alignment of director interests with shareholders through equity-based compensation.

Negatives

• Potential future dilution of existing shareholders upon the exercise of these options.

Risks

• Market price volatility affecting the value of the granted options.
• General risks associated with the healthcare industry and regulatory environment.

Future Outlook

The filing does not provide forward-looking financial guidance, as it is a standard disclosure of director compensation.

Industry Context

StockSavvy.ai notes that equity grants to directors are standard corporate governance practices intended to incentivize long-term performance and align leadership with shareholder interests within the healthcare services sector.

Comparison to Industry Standards

• The use of an Omnibus Equity Incentive Plan is consistent with standard compensation practices for publicly traded healthcare companies.
• The four-year vesting/expiration window is typical for director-level equity compensation.

Corporate Governance

Stakeholder Impact

• Shareholders may experience minor dilution if these options are exercised.

Next Steps

• The reporting person may choose to exercise these options at any time prior to the expiration date of May 6, 2030.

Key Dates

Keywords

National HealthCare Corp, NHC, Form 4, Insider Trading, Stock Options, Equity Incentive Plan